The Next 150 Raises $2 Million USD to Scale Climate Solutions in Emerging Markets

GENÈVE, SWITZERLAND and MEXICO CITY, MEXICO / March 16, 2023 / The Next 150, a climate-forward venture operator, has announced its official launch with offices in Switzerland and Mexico. The company is focused on scaling climate solutions in emerging markets to support the transition to a low-carbon economy.

Related Image

The Next 150 Logo
The Next 150 Company logo uses a symbol of movement, for transformation of key ideas into concrete plans and actions, with an interpolation of elements from one key moment into another.

The Next 150, founded by Patrick Atanasije Pineda and Constantin Ekierman, has raised $2 million in seed capital from Kemexon SA, with additional capital earmarked for investment to develop, scale and industrialize climate technologies, such as biochar production from waste biomass and its incorporation in soil and construction materials.

The Kemexon group is a global trading and supply chain logistics company with over 20 years of activity across a range of commodity products. “We look forward to exploring opportunities and uncovering synergies with our existing interests in biomass markets, in support of the energy transition and a path to decarbonization.” – Alexia Bricout, co-CEO of Kemexon

The Intergovernmental Panel on Climate Change, IPCC, estimates that by 2050, we will need to remove 3-12 billion tons of CO2 from the air every year in order to meet the Paris Agreement goals. The Next 150 is developing high-quality emissions removal projects with a boots-on-the-ground approach.

About The Next 150

Ekierman and Pineda bring a unique set of experiences that has spanned executing over $350M USD in carbon markets, to building ISO-certified agricultural production and processing facilities. These projects and investments include inking a deal with a UEFA Champions League team for their carbon abatement goals, and the origination and structuring of a large-scale, high-tech biochar project in Latam, with an installed capacity of 50,000MT of biomass waste.

The Next 150’s Mexico office is led by Luisa Marin, Country Director, bringing 25 years of experience from the international development sector having managed multi-stakeholder initiatives at The Nature Conservancy and Conservation International. The office has an experienced technical team headed by Benjamin Pozos, Technical Director, a lead verifier in carbon projects in Mexico under ISO 14064:3 and an industry veteran.

According to the International Monetary Fund, private sustainable finance in emerging markets and developing economies reached a record of $250 billion last year. The Next 150 will capitalize on the growth of green finance and carbon markets, utilizing its in-house operational experience to invest and operate in the global south, ensuring that local projects make a global impact.

Contact Information

Rafael Gamboa
Director of Communications
rafael@thenext150.com
+52 55 3227 3531

SOURCE: The Next 150 SA de CV

ART MEDICAL Announces Partnership With Teva Israel to Bring Its Lifesaving Technology to Critical Care Units

ART MEDICAL Ltd. is pleased to announce its collaboration with Teva Israel. Under the terms of the agreement, Teva Israel will market and distribute ART MEDICAL’s ground-breaking smART+ Platform in Israel’s intensive care units.

NETANYA, ISRAEL / ACCESSWIRE / March 16, 2023 / The smART+ Platform is a robotic-assisted technology that aims to reduce complications related to feeding tube malposition, malnutrition, Ventilator-Associated Pneumonia (VAP), and Acute Kidney Injury (AKI). By delivering transformative new-to-the-world data, the smART+ Platform enables medical staff to take a comprehensive approach to critical care, make informed decisions and improve patient outcomes.

Related Image

Current related practices in intensive care units rely mostly on manual work and cumbersome procedures. ICU patients are routinely subjected to the risks of malnutrition, tube malposition, and pneumonia. Without technological solutions, nutrition treatment leads to inaccuracies, increased workloads on care teams, and generic nutrition plans that are neither personalized nor updated in real time. The smART+ Platform uses a proprietary sensor-based feeding tube, continuous metabolic assessment, and algorithms, to provide real-time monitoring and closed-loop feedback, resulting in better and personalized care for critically ill patients.

ART MEDICAL’s Founder and CEO, Liron Elia, says, “Our goal, at ART MEDICAL, is to improve patient outcomes through cutting-edge technology. By integrating real-time data, monitoring, and control mechanisms, the smART+ Platform addresses several of the greatest clinical challenges of intensive care units. This powerful combination provides a comprehensive and innovative nutritional therapy practice as well as optimized care delivery. We are thrilled to partner with Teva Israel to bring our technology to critically ill patients and clinical teams in ICUs.”

Yossi Ofek, GM-Teva Israel, SVP; Cluster Head – Middle East, Africa & Ukraine says:

“Teva Israel continually strives to offer innovative and safe treatment options – both in the community and in hospitals – in order to improve the lives and health of patients.

“The innovative development of an Israeli company, ART MEDICAL, is intended to ensure that patients in intensive care units receive the most advanced treatment offered today that can minimize complications related to hospitalization and reduce length of stay.”

About Teva Israel:

‘Teva Israel’ is the home-based marketing arm of Teva Pharmaceutical Industries Ltd, where it has been working to improve the lives and health of patients, for over 120 years, through high-quality and affordable medicines.

As a leading player in the local health market and particularly in the generics and OTC markets, Teva Israel provides unique services in Israel to Israeli residents, through its logistics company SLE – and markets a wide variety of medicines and products: from original innovative medicines and generic medicines, through medical equipment and devices for hospitals, to over the counter (OTC) medicines and baby milk formula.

Teva Israel is also an innovation incubator for Teva Global and established, in collaboration with Philips, Sanara Ventures, a platform for investments in start-up companies in the fields of digital medicine and medical devices. In Israel, one of every four prescriptions is for a Teva drug, while the annual savings that the company’s generic drugs bring to the Israeli healthcare system is estimated at about one and a half billion shekels, per year.

About ART MEDICAL

ART MEDICAL is on a mission to save lives through technological innovations and redefine the future of critical care. Our goal is to see ICU patients get better faster with the help of real-time nutrition management. Visit www.artmedical.com or follow us on LinkedIn for more information.

Forward-Looking Statements of ART MEDICAL

ART MEDICAL developed the smART+™ Platform as a holistic approach for the next-generation ICU, featuring an ecosystem of sensor-based tools, software, and algorithms. smART+ is designed to prevent ICU-acquired complications. The smART+ Platform aims to reduce length of ventilation days and length of stay that are attributed to malnutrition, VAP, and other secondary infections and complications, ultimately providing better care, and dramatically reducing healthcare costs.

Disclaimer

THIS PRESS RELEASE AND ITS CONTENT IS NOT INTENDED AS AN OFFERING OR AS A SOLICITATION TO AN OFFERING TO PURCHASE SECURITIES OF ANY OF THE ABOVE-MENTIONED COMPANIES OR ANY OF THEIR AFFILIATES, DIRECTLY OR INDIRECTLY, AND YOU MAY NOT RELY ON THIS PRESS RELEASE IN CONNECTION WITH AN INVESTMENT DECISION.

Contact Information

Ori Braun
SVP Business Development
press@artmedical.com

SOURCE: ART MEDICAL

Sustainalytics Upgrades INNIO Group’s ESG Risk Rating From Low to Negligible Risk, Ranking INNIO Number 1 Worldwide Among Industry Peers

Sustainalytics ESG rating places INNIO in top 1 percentile of all industry peers and in top 2 percentile of companies rated by Sustainalytics on a global level. • INNIO receives Sustainalytics’ ESG risk score of 9.8, improving by 11% compared to 2022. • INNIO also receives Sustainalytics’ 2023 “ESG Industry Top rated” and “ESG Regional Top Rated” badges.

JENBACH, AUSTRIA / ACCESSWIRE / March 16, 2023 / INNIO today announced that Sustainalytics has upgraded INNIO Group’s ESG risk score to 9.8, an improvement of 1.2 points year-over-year, and has upgraded the company’s risk rating from low to negligible. The rating from Sustainalytics, a global leader in ESG research, ratings, and data, reinforces INNIO’s number 1 position compared to peers across both Machinery and Industrial Machinery worldwide.

“Improving our Sustainalytics rating is not only a reflection of our dedication to environmental, social and governance responsibility, it is also a testament to the hard work and collaboration of our talented team,” said Dr. Olaf Berlien, president and CEO of INNIO. “We will continue to prioritize sustainable practices and innovation for the benefit of our business, our stakeholders, and our planet.”

The Sustainalytics risk rating improvement is a vital recognition for INNIO and an indicator of the company’s commitment to sustainable policies and programs. The risk rating focus includes health and safety, environment and carbon management, human capital, procurement practices and circularity. The rating upgrade signals that INNIO’s initiatives and actions to reduce its environmental impact, promote social equity, and ensure good governance are demonstrating positive results. It also underlines INNIO’s commitment to transparency and accountability, which are important factors in building trust and credibility with stakeholders, including customers, suppliers, investors, and employees.

Learn more about the ESG Risk Ratings.

About Sustainalytics

Sustainalytics is a global leader in ESG research, ratings, and data, serving the world’s leading institutional investors and corporations. Sustainalytics works with hundreds of the world’s leading asset managers and pension funds who incorporate ESG and corporate governance information and assessments into their investment processes. For more information regarding Sustainalytics ESG rating, please visit https://www.sustainalytics.com/esg-ratings.

About INNIO 

INNIO is a leading energy solution and service provider that empowers industries and communities to make sustainable energy work today. With our product brands Jenbacher and Waukesha and our digital platform myPlant, INNIO offers innovative solutions for the power generation and compression segments that help industries and communities generate and manage energy sustainably while navigating the fast-changing landscape of traditional and green energy sources. We are individual in scope, but global in scale. With our flexible, scalable, and resilient energy solutions and services, we are enabling our customers to manage the energy transition along the energy value chain wherever they are in their transition journey.

INNIO is headquartered in Jenbach (Austria), with other primary operations in Waukesha (Wisconsin, U.S.) and Welland (Ontario, Canada). A team of more than 4,000 experts provides life-cycle support to the more than 55,000 delivered engines globally through a service network in more than 100 countries.

INNIO’s improved ESG Risk Rating again secures the number one position across more than 500 companies globally in the machinery industry assessed by Sustainalytics.

For more information, visit INNIO’s website at www.innio.com. Follow INNIO on Twitter and LinkedIn.

Contact Information

Susanne Reichelt
INNIO Media Relations
susanne.reichelt@innio.com
+43 664 80833 2382

Related Image

SOURCE: INNIO Group

De Novo Dairy Announces Rebrand and Headquarters Move to London

De Novo Dairy, a leading precision fermentation company, announced today its official rebrand to De Novo Foodlabs. The new name reflects the company’s expanded focus on creating sustainable nutrients that improve the health of people and the planet through precision fermentation and other technologies.

LONDON, ENGLAND / ACCESSWIRE / March 16, 2023 / De Novo Dairy, a leading precision fermentation company, announced today its official rebrand to De Novo Foodlabs. The new name reflects the company’s expanded focus on creating sustainable nutrients that improve the health of people and the planet through precision fermentation and other technologies.

Related image

De Novo Foodlabs Rebrand
De Novo Foodlabs new logo and brand

 

De Novo Foodlabs’ proprietary precision fermentation platform enables the creation of high-quality and nutrient-rich ingredients from non-animal sources. The company’s technology is at the forefront of a global movement towards a more sustainable and ethical food system.

With its headquarters move to London in quarter four of 2023, De Novo Foodlabs will be at the heart of Europe’s vibrant foodtech community. This strategic relocation will allow the company to strengthen its partnerships with leading food and beverage companies, research institutions and investors.

“We are thrilled to be rebranding to De Novo Foodlabs and relocating our headquarters to London. This is a significant milestone in our company’s journey,” said CEO Jean Louwrens. “Our new name and broader focus reflect our commitment to creating a better food system for everyone, and we are excited to be at the forefront of this movement.”

The rebranding of De Novo Dairy to De Novo Foodlabs represents a significant shift for the company as it continues to lead the way in the precision fermentation space. With its innovative technology, De Novo Foodlabs is set to make a significant impact on the global food system by creating sustainable, nutritious and commercially attractive ingredients.

For more information on De Novo Foodlabs and its precision fermentation technology, visit www.denovofoodlabs.com

Contact Information

Samantha Ritchie
Media Liaison, Little Biggies
press@littlebiggies.com

SOURCE: De Novo Foodlabs

Play Ball! Major League Baseball and Zoom Announce First-of-its-kind Partnership; Zoom Contact Center to Power ‘Zoom Replay Operations Center’

  • Zoom becomes Official Unified Communications Platform of MLB and Presenting Partner of MLB Replay Review
  • MLB to introduce league-first, broadcast look-ins from the Zoom Replay Operations Center
  • Zoom Contact Center, Zoom Events, and Zoom’s all-in-one collaboration platform will deliver unprecedented transparency to the fans and enhanced communications between front office staff, umpires, and league officials

SAN JOSE, Calif. and NEW YORK, March 16, 2023 (GLOBE NEWSWIRE) — Major League Baseball (MLB) and Zoom Video Communications, Inc. (NASDAQ: ZM) today announced a first-of-its-kind partnership for the league, aimed to enhance MLB games and the fan viewership experience. As the new Official Unified Communications Platform of MLB, Zoom Contact Center and the Zoom platform technology will power new elements of Major League games and broadcasts.

MLB Chief Operations & Strategy Officer Chris Marinak, said: “We are always looking for innovative ways to leverage best-in-class technology to advance the MLB experience and deliver more to our fans. Partnering with Zoom, a category leader that reinvented the way we connect, was a natural next step for us. We are excited to integrate Zoom Contact Center and other Zoom platform technology into our gameday operations and continue to modernize experiences in a secure, reliable, and innovative way.”

Zoom Chief Marketing Officer, Janine Pelosi said: “MLB brings together tens of millions of passionate fans every season. Zoom’s rapid pace of innovation and obsession with making human connection easier and better, is crucial to help MLB evolve its experience and deliver unprecedented transparency and access to its fans. With MLB leveraging Zoom Contact Center and Zoom’s all-in-one collaboration platform, we are able to truly show the world how a historical brand can continue to innovate and unlock new possibilities.”

Zoom platform integration drives MLB innovations:

  • Zoom Contact Center transforms replay review – In the 2022 MLB season, there were more than 1,400 replay reviews. Historically, the league’s replay review was reliant on disparate technology and audio-only communication with umpires on the field, resulting in fans being disconnected from the decision-making process.

    Beginning with the 2023 Season, the Crew Chief, the most senior member of the four-man umpire crew, will connect to the Zoom Replay Operations Center using Zoom’s Contact Center solution during any replay review. During national broadcasts on MLB Network and Apple TV+, fans will also see the Zoom Replay Operations Center in action live during replay reviews and hear from an expert rules analyst who will discuss replay reviews with the broadcast team. MLB’s goal with this new setup is to create a more transparent and engaging review process.

  • Zoom Platform helps streamline communication – Zoom will be used to securely deliver sensitive information in one of the most high-pressure and high-profile MLB Events, Day One of the 2023 MLB Draft.
  • Broader league-wide Zoom integrations advance collaboration – Zoom’s all-in-one collaboration platform is integrated across several MLB clubs, platforms, and broadcast outlets. In addition to Zoom Meetings, many MLB teams are using Zoom Phone to stay connected with colleagues and customers, as well as Zoom Contact Center to deliver prompt, accurate, and highly personalized customer experiences to their fans. MLB’s corporate offices use Zoom Meetings, Zoom Rooms, Zoom Phone, and Zoom Webinar to connect, collaborate, and communicate.

To learn more about the Zoom platform and the technology that will power several new elements in MLB starting in the 2023 season, read the blog here.

About MLB
Major League Baseball (MLB) is the most historic professional sports league in the United States and consists of 30 member clubs in the U.S. and Canada, representing the highest level of professional baseball. Led by Commissioner Robert D. Manfred, Jr., MLB remains committed to making an impact in the communities of the U.S., Canada and throughout the world, perpetuating the sport’s larger role in society and permeating every facet of baseball’s business, marketing, community relations and social responsibility endeavors. MLB currently features record levels of competitive balance, continues to expand its global reach through programming and content to fans all over the world, and registered records in games and minutes watched this season on MLB.TV. With the continued success of MLB Network and MLB digital platforms, MLB continues to find innovative ways for its fans to enjoy America’s National Pastime and a truly global game. For more information on Major League Baseball, visit www.MLB.com.

About Zoom
Zoom is an all-in-one intelligent collaboration platform that makes connecting easier, more immersive, and more dynamic for businesses and individuals. Zoom technology puts people at the center, enabling meaningful connections, facilitating modern collaboration, and driving human innovation through solutions like team chat, phone, meetings, omnichannel cloud contact center, smart recordings, whiteboard, and more, in one offering. Founded in 2011, Zoom is publicly traded (NASDAQ:ZM) and headquartered in San Jose, California. Get more info at zoom.com.

MLB Communications
David Hochman
david.hochman@mlb.com

Zoom Public Relations
Candace Dean
press@zoom.us

GlobeNewswire Distribution ID 8789553

EveLab Insight Releases Latest Product Feature — Glow Detection, Helping Beauty Businesses Upgrade Personalized Skincare Solutions Through AI Skin Analysis System

EveLab Insight, a leading AI skin analysis company, is pleased to announce the release of its newest feature – Glow Detection

SINGAPORE / ACCESSWIRE / March 16, 2023 / EveLab Insight, a leading AI skin analysis company, is pleased to announce the release of its newest feature of its 3D skin analysis system – Glow Detection. For decades, consumers have sought the perfect product to achieve “glowing” skin. After working with dozens of industry-leading brands, such as Shiseido and Dior, EveLab Insight has developed a scientific and repeatable way to assist brands in helping their clients’ skin achieve a healthy radiance.

AI Skin Analysis System

EveLab Insight professional skin analysis machine empowers beauty businesses through in-depth skincare insights.

Drawing on years of skin research, EveLab Insight uses advanced imaging technology and parallel polarized light to accurately detect skin issues at both the surface and deep levels of the skin. Advanced algorithm training and deep learning allow EveLab Insight’s professional skin analysis machine to identify and analyze key dimensions contributing to glowing skin: oiliness condition, skin texture, and evenness of skin tone. Leveraging this information, brands can confidently recommend customized skincare solutions based on individual needs.

EveLab Insight’s skin analysis system offers more than just a tool for ground-level analysis. Its insights on skincare empower enterprises across all departments, from R&D to marketing to brand ambassadors. R&D teams can leverage EveLab Insight’s generated skincare insights to develop products that meet market demands, while the customizable UI can help marketing departments highlight key product features. Most importantly, brand ambassadors can use the AI skin analysis tool to enhance customer experience and build trust between consumers and the brand.

EveLab Insight believes that achieving a glossy complexion is not just about external factors, but also about maintaining a healthy skin barrier. With the Glow Detection feature, EveLab Insight hopes to empower individuals and enterprises alike to take a more holistic approach to skincare and achieve their best, most radiant selves.

About EveLab Insight

EveLab Insight’s AI skin analysis feature is a game-changer for the skincare industry. With its precise detection system and customizable recommendations, it not only helps customers achieve healthier skin but also empowers companies to make better business decisions. Based on award-winning algorithms and patented technologies, EveLab Insight offers panoramic AI skin analyzers, a hand-held skin analyzer, and a photo-based skin analysis app for O2O scenarios.

Please visit our website to unlock more tips to accelerate your beauty business: www.evelabinsight.com.

Contact Information

Daisy Zhang
Marketing Manager
daisy.zhang@evelabinsight.com

SOURCE: EveLab Insight

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Atlassian Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – TEAM

NEW YORK, March 15, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Atlassian Corporation (NASDAQ: TEAM) between August 5, 2022 and November 3, 2022, both dates inclusive (the “Class Period”), of the important April 4, 2023 lead plaintiff deadline.

SO WHAT: If you purchased Atlassian common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Atlassian class action, go to https://rosenlegal.com/submit-form/?case_id=11753 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 4, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) macroeconomic factors were having a material adverse impact on Atlassian’s business; (2) the slowing conversions from free to paid customers the Company was experiencing constituted a negative trend; (3) paid user growth also had slowed; and (4) as a result, defendants’ positive statements about the Company’s financial guidance, business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Atlassian class action, go to https://rosenlegal.com/submit-form/?case_id=11753 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8789054

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages BlockFi Interest Account Investors to Secure Counsel Before Important Deadline in Securities Class Action Against Zac Prince, Flori Marquez, Amit Cheela, David Olsson, and Samia Bayou

NEW YORK, March 15, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds investors in BlockFi Interest Accounts (“BIAs”) between March 4, 2019 and November 28, 2022, inclusive (the “Class Period”), against Zac Prince, Flori Marquez, Amit Cheela, David Olsson, and Samia Bayou (together, “Defendants”), of the important May 1, 2023 lead plaintiff deadline.

SO WHAT: If you invested in BlockFi Interest Accounts (“BIAs”) during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the BlockFi class action, go to https://rosenlegal.com/submit-form/?case_id=12656 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 1, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, the Defendants made false and misleading statements to promote BlockFi Interest Accounts (“BIAs”), including that BIAs were a secure method of collecting interest. In addition, the Complaint alleges, among other things, that the defendants omitted and concealed material information concerning the risks associated with BIAs, including through BlockFi’s exposure to FTX Trading, Ltd. (“FTX”) and Sam Bankman-Fried’s trading firm Alameda Research (“Alameda”), both of which collapsed in the wake of revelations that FTX and Alameda were engaging in fraud on a massive scale. In the wake of the FTX collapse, the lawsuit alleges that BlockFi froze withdrawals in BIAs, harming BIA investors. Further, investors in BIAs were not aware of conflicts of interest and self-dealing between BlockFi and other entities, such as Gemini Trust LLC, controlled by Tyler and Cameron Winklevoss. The Complaint further alleges BlockFi and the Individual Defendants engaged in the unlawful offer and sale of securities in violation of Sections 5, 11, 12(a)(2), and 15 of the Securities Act of 1933 by selling BIAs to investors. The lawsuit also alleges claims for violation of Section 10(b) and 20 of the Securities Exchange Act of 1934 and Massachusetts General Law Chapter 110A.

To join the BlockFi class action, go to https://rosenlegal.com/submit-form/?case_id=12656 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8789064

ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CRBU

NEW YORK, March 15, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Caribou Biosciences, Inc. (NASDAQ: CRBU): (i) pursuant and/or traceable to the offering documents and related prospectus issued in connection with the Company’s 2021 initial public offering conducted on or about July 23, 2021 (the “IPO” or “Offering”); and/or (ii) between July 23, 2021 and December 9, 2022, both dates inclusive (the “Class Period”), of the important April 11, 2023 lead plaintiff deadline.

SO WHAT: If you purchased Caribou securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Caribou class action, go to https://rosenlegal.com/submit-form/?case_id=11988 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 11, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, the Offering documents were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation. Additionally, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects. Specifically, the Offering documents and defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) CB-010’s treatment effect was not as durable as defendants had led investors to believe; (2) accordingly, CB-010’s clinical and commercial prospects were overstated; and (3) as a result, the Offering documents and defendants’ public statements throughout the Class Period were materially false and/or misleading and failed to state information required to be stated therein.

To join the Caribou class action, go to https://rosenlegal.com/submit-form/?case_id=11988 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8789065

ROSEN, A RANKED AND LEADING FIRM, Encourages Argo Blockchain plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – ARBK

NEW YORK, March 15, 2023 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the American Depository Shares (“ADSs”) of Argo Blockchain plc (NASDAQ: ARBK): (i) pursuant and/or traceable to the Offering Documents issued in connection with the Company’s initial public offering conducted on or about September 23, 2021 (the “IPO” or “Offering”); and/or (ii) securities between September 23, 2021 and October 10, 2022, both dates inclusive (the “Class Period”), of the important March 27, 2023 lead plaintiff deadline.

SO WHAT: If you purchased Argo securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Argo class action, go to https://rosenlegal.com/submit-form/?case_id=11508 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 27, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, the Offering Documents and defendants made false and/or misleading statements and/or failed to disclose that: (1) Argo was highly susceptible to and/or suffered from significant capital constraints, electricity and other costs, and network difficulties; (2) the foregoing issues hampered, inter alia, Argo’s ability to mine BTC, execute its business strategy, meet its obligations, and operate its Helios facility; (3) as a result, Argo’s business was less sustainable than Defendants had led investors to believe; (4) accordingly, Argo’s business and financial prospects were overstated; and (5) as a result, the Offering Documents and Defendants’ public statements throughout the Class Period were materially false and/or misleading and failed to state information required to be stated therein. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Argo class action, go to https://rosenlegal.com/submit-form/?case_id=11508 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8789038

AMGN ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Amgen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AMGN

NEW YORK, March 15, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Amgen Inc. (NASDAQ: AMGN) between July 29, 2020 and April 27, 2022, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 12, 2023.

SO WHAT: If you purchased Amgen securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Amgen class action, go to https://rosenlegal.com/submit-form/?case_id=13114 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 12, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) the U.S. government claimed Amgen owed more than $3 billion in back taxes for tax years 2010, 2011, and 2012; (2) the U.S. government claimed Amgen owed more than $5 billion in back taxes for tax years 2013, 2014, and 2015; (3) the U.S. government would likely claim Amgen owed materially more to the U.S. government than investors had been led to believe for subsequent tax years for which the Company had used the same profit allocation treatment between its U.S. and Puerto Rico operations; (4) Amgen had not taken sufficient accruals to account for its outstanding tax liabilities; (5) Amgen had failed to comply with ASC 450 and other rules and regulations regarding the preparation of its periodic SEC filings; and (6) Amgen’s refusal to pay taxes claimed by the U.S. government exposed the Company to a substantial risk of severe financial penalties imposed by the IRS. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Amgen class action, go to https://rosenlegal.com/submit-form/?case_id=13114 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8789045